Related Experiment Video
Updated: Jul 10, 2026
09:02
Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model
Published on: September 27, 2024
Targeted drug therapy for meningiomas
Andrew D Norden1, Jan Drappatz, Patrick Y Wen
1Division of Neuro-Oncology, Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
Neurosurgical Focus
|October 27, 2007
Summary
Targeted molecular therapies offer new hope for patients with recurrent or progressive meningiomas, especially when conventional treatments like surgery and radiation fail. This review explores these advanced treatment options.
Area of Science:
- Neuro-oncology
- Neurosurgery
- Medical Oncology
Background:
- Meningiomas are tumors arising from the meninges.
- Advances in surgery, radiation, and stereotactic radiosurgery have improved outcomes.
- A subset of meningiomas remains refractory to conventional therapies, with limited benefit from traditional chemotherapy.
Purpose of the Study:
- To review the role of targeted molecular therapies for meningiomas.
- To discuss treatment options for recurrent or progressive meningiomas.
Main Methods:
- Literature review of targeted molecular therapies for meningiomas.
- Analysis of treatment efficacy and mechanisms of action.
Main Results:
- Traditional chemotherapy offers minimal benefit for refractory meningiomas.
- Targeted molecular therapies represent a promising avenue for managing difficult-to-treat meningiomas.
Conclusions:
- Targeted molecular therapies are crucial for addressing treatment resistance in meningiomas.
- Further research into molecular pathways is needed to optimize targeted treatment strategies.
More Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...